Alexander Barker
Concepts (424)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Valve | 67 | 2024 | 352 | 11.760 |
Why?
| | Heart Valve Diseases | 53 | 2024 | 152 | 9.840 |
Why?
| | Hemodynamics | 77 | 2024 | 1114 | 8.260 |
Why?
| | Magnetic Resonance Angiography | 44 | 2025 | 240 | 7.920 |
Why?
| | Aorta | 56 | 2024 | 421 | 7.640 |
Why?
| | Imaging, Three-Dimensional | 56 | 2025 | 581 | 6.250 |
Why?
| | Blood Flow Velocity | 74 | 2024 | 412 | 5.580 |
Why?
| | Magnetic Resonance Imaging | 80 | 2025 | 3722 | 5.340 |
Why?
| | Magnetic Resonance Imaging, Cine | 36 | 2025 | 193 | 4.980 |
Why?
| | Image Interpretation, Computer-Assisted | 30 | 2025 | 279 | 4.080 |
Why?
| | Aorta, Thoracic | 23 | 2023 | 267 | 3.980 |
Why?
| | Aortic Diseases | 23 | 2024 | 117 | 3.870 |
Why?
| | Aortic Valve Stenosis | 22 | 2022 | 229 | 3.750 |
Why?
| | Stress, Mechanical | 33 | 2024 | 475 | 2.940 |
Why?
| | Aortic Aneurysm, Thoracic | 8 | 2023 | 131 | 2.070 |
Why?
| | Pulmonary Artery | 17 | 2024 | 1083 | 2.020 |
Why?
| | Regional Blood Flow | 22 | 2024 | 474 | 1.980 |
Why?
| | Fetal Heart | 4 | 2025 | 55 | 1.970 |
Why?
| | Predictive Value of Tests | 33 | 2025 | 2039 | 1.970 |
Why?
| | Shear Strength | 15 | 2024 | 67 | 1.920 |
Why?
| | Ventricular Function, Left | 16 | 2024 | 540 | 1.700 |
Why?
| | Vascular Stiffness | 17 | 2024 | 492 | 1.670 |
Why?
| | Heart Ventricles | 17 | 2024 | 792 | 1.530 |
Why?
| | Echocardiography, Doppler | 5 | 2024 | 109 | 1.510 |
Why?
| | Reproducibility of Results | 33 | 2025 | 3292 | 1.390 |
Why?
| | Models, Cardiovascular | 12 | 2021 | 195 | 1.380 |
Why?
| | Image Enhancement | 12 | 2022 | 194 | 1.320 |
Why?
| | Perfusion Imaging | 14 | 2024 | 58 | 1.320 |
Why?
| | Pregnancy Trimester, Third | 3 | 2025 | 113 | 1.260 |
Why?
| | Ultrasonography, Prenatal | 4 | 2025 | 284 | 1.220 |
Why?
| | Tetralogy of Fallot | 8 | 2022 | 78 | 1.210 |
Why?
| | Humans | 192 | 2025 | 137514 | 1.170 |
Why?
| | Echocardiography, Four-Dimensional | 3 | 2024 | 8 | 1.080 |
Why?
| | Female | 124 | 2025 | 73162 | 1.050 |
Why?
| | Aortic Coarctation | 8 | 2025 | 83 | 1.040 |
Why?
| | Terminology as Topic | 4 | 2024 | 216 | 0.990 |
Why?
| | Cardiac-Gated Imaging Techniques | 10 | 2025 | 21 | 0.990 |
Why?
| | Contrast Media | 11 | 2022 | 462 | 0.980 |
Why?
| | Hypertension, Pulmonary | 11 | 2023 | 1903 | 0.970 |
Why?
| | Male | 121 | 2025 | 67718 | 0.950 |
Why?
| | Image Processing, Computer-Assisted | 11 | 2025 | 784 | 0.950 |
Why?
| | Heart Valve Prosthesis Implantation | 6 | 2019 | 182 | 0.950 |
Why?
| | Gestational Age | 4 | 2025 | 903 | 0.940 |
Why?
| | Heart Defects, Congenital | 12 | 2025 | 832 | 0.930 |
Why?
| | Fontan Procedure | 8 | 2024 | 179 | 0.880 |
Why?
| | Myocardial Perfusion Imaging | 8 | 2020 | 40 | 0.880 |
Why?
| | Adult | 73 | 2025 | 37821 | 0.880 |
Why?
| | Retrospective Studies | 49 | 2025 | 15628 | 0.850 |
Why?
| | Ventricular Function, Right | 12 | 2024 | 283 | 0.840 |
Why?
| | Iothalamic Acid | 1 | 2022 | 5 | 0.810 |
Why?
| | Coronary Circulation | 10 | 2020 | 141 | 0.780 |
Why?
| | Observer Variation | 6 | 2023 | 347 | 0.770 |
Why?
| | Middle Aged | 63 | 2025 | 33355 | 0.740 |
Why?
| | Young Adult | 41 | 2024 | 13243 | 0.720 |
Why?
| | Pulmonary Circulation | 6 | 2019 | 430 | 0.710 |
Why?
| | Cardiac Surgical Procedures | 5 | 2020 | 531 | 0.710 |
Why?
| | Hydrodynamics | 4 | 2022 | 42 | 0.710 |
Why?
| | Ventricular Dysfunction, Right | 6 | 2022 | 236 | 0.700 |
Why?
| | Problem-Based Learning | 1 | 2021 | 90 | 0.700 |
Why?
| | Sensitivity and Specificity | 15 | 2016 | 1950 | 0.700 |
Why?
| | Motion Pictures | 1 | 2020 | 20 | 0.680 |
Why?
| | Electrocardiography | 4 | 2020 | 632 | 0.670 |
Why?
| | Child | 43 | 2024 | 22037 | 0.670 |
Why?
| | Reference Values | 9 | 2024 | 821 | 0.660 |
Why?
| | Bicuspid | 2 | 2018 | 17 | 0.660 |
Why?
| | Arterial Pressure | 7 | 2019 | 126 | 0.660 |
Why?
| | Tobacco Use | 1 | 2020 | 66 | 0.650 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2020 | 389 | 0.650 |
Why?
| | Nuclear Physics | 6 | 2014 | 13 | 0.640 |
Why?
| | Algorithms | 12 | 2025 | 1702 | 0.620 |
Why?
| | Tobacco Products | 1 | 2020 | 142 | 0.610 |
Why?
| | Anesthesia | 1 | 2022 | 191 | 0.610 |
Why?
| | Adolescent | 41 | 2024 | 21555 | 0.600 |
Why?
| | Aged | 40 | 2024 | 23798 | 0.590 |
Why?
| | Pulse Wave Analysis | 9 | 2023 | 269 | 0.560 |
Why?
| | Case-Control Studies | 20 | 2023 | 3546 | 0.560 |
Why?
| | Severity of Illness Index | 11 | 2019 | 2838 | 0.530 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2024 | 121 | 0.530 |
Why?
| | Models, Theoretical | 7 | 2017 | 576 | 0.510 |
Why?
| | Cardiac Imaging Techniques | 8 | 2021 | 22 | 0.510 |
Why?
| | Aortography | 3 | 2021 | 52 | 0.510 |
Why?
| | C-Peptide | 2 | 2014 | 163 | 0.500 |
Why?
| | Aortic Aneurysm | 6 | 2024 | 65 | 0.500 |
Why?
| | Systole | 9 | 2022 | 191 | 0.480 |
Why?
| | Prospective Studies | 18 | 2024 | 7598 | 0.470 |
Why?
| | Gadolinium DTPA | 2 | 2018 | 70 | 0.470 |
Why?
| | Arteriosclerosis | 2 | 2014 | 88 | 0.460 |
Why?
| | Kidney | 1 | 2022 | 1472 | 0.460 |
Why?
| | Feasibility Studies | 10 | 2019 | 950 | 0.450 |
Why?
| | Aging | 2 | 2015 | 1866 | 0.430 |
Why?
| | Elementary Particles | 4 | 2014 | 12 | 0.430 |
Why?
| | Hemorheology | 1 | 2013 | 22 | 0.430 |
Why?
| | Dilatation, Pathologic | 7 | 2024 | 61 | 0.430 |
Why?
| | Cardiovascular Diseases | 7 | 2024 | 2113 | 0.420 |
Why?
| | Age Factors | 11 | 2024 | 3301 | 0.420 |
Why?
| | Marfan Syndrome | 3 | 2018 | 41 | 0.420 |
Why?
| | Stroke Volume | 9 | 2022 | 619 | 0.420 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 39 | 0.410 |
Why?
| | Insulin Antibodies | 1 | 2013 | 105 | 0.410 |
Why?
| | Computer Simulation | 6 | 2021 | 986 | 0.410 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2024 | 3708 | 0.400 |
Why?
| | Norwood Procedures | 2 | 2024 | 29 | 0.400 |
Why?
| | Hyperventilation | 1 | 2012 | 10 | 0.390 |
Why?
| | Insulin-Secreting Cells | 2 | 2014 | 372 | 0.390 |
Why?
| | Pilot Projects | 10 | 2022 | 1703 | 0.370 |
Why?
| | Heart Valve Prosthesis | 4 | 2017 | 116 | 0.370 |
Why?
| | Awareness | 1 | 2012 | 104 | 0.360 |
Why?
| | Acceleration | 1 | 2011 | 31 | 0.360 |
Why?
| | Vascular Remodeling | 5 | 2019 | 190 | 0.360 |
Why?
| | Child, Preschool | 17 | 2022 | 11097 | 0.340 |
Why?
| | Mitral Valve Stenosis | 2 | 2022 | 18 | 0.330 |
Why?
| | Phantoms, Imaging | 5 | 2022 | 151 | 0.330 |
Why?
| | Artifacts | 4 | 2025 | 137 | 0.320 |
Why?
| | Biomechanical Phenomena | 6 | 2023 | 768 | 0.320 |
Why?
| | Fetus | 2 | 2025 | 807 | 0.320 |
Why?
| | Electroencephalography | 1 | 2012 | 438 | 0.320 |
Why?
| | Phenotype | 9 | 2021 | 3205 | 0.310 |
Why?
| | Cardiovascular System | 2 | 2023 | 141 | 0.290 |
Why?
| | Postoperative Complications | 5 | 2020 | 2641 | 0.270 |
Why?
| | Ventricular Remodeling | 5 | 2022 | 262 | 0.260 |
Why?
| | Heart Function Tests | 2 | 2019 | 61 | 0.260 |
Why?
| | Principal Component Analysis | 2 | 2024 | 197 | 0.260 |
Why?
| | Time Factors | 14 | 2024 | 6817 | 0.250 |
Why?
| | Cross-Sectional Studies | 7 | 2024 | 5427 | 0.240 |
Why?
| | Biomarkers | 8 | 2023 | 4172 | 0.240 |
Why?
| | Blood Vessel Prosthesis Implantation | 2 | 2019 | 202 | 0.230 |
Why?
| | Blood Circulation | 1 | 2024 | 41 | 0.230 |
Why?
| | Prenatal Diagnosis | 2 | 2025 | 202 | 0.230 |
Why?
| | Infant, Newborn | 5 | 2023 | 6059 | 0.230 |
Why?
| | Pulmonary Valve Insufficiency | 2 | 2022 | 43 | 0.230 |
Why?
| | Cross-Over Studies | 2 | 2024 | 561 | 0.230 |
Why?
| | Neoplasm, Residual | 1 | 2025 | 133 | 0.220 |
Why?
| | Placental Circulation | 1 | 2025 | 70 | 0.220 |
Why?
| | Follow-Up Studies | 7 | 2021 | 5139 | 0.220 |
Why?
| | Hypoglycemic Agents | 1 | 2013 | 1285 | 0.220 |
Why?
| | Viscosity | 3 | 2019 | 92 | 0.220 |
Why?
| | Ultrasonography, Doppler | 1 | 2025 | 123 | 0.220 |
Why?
| | Myocardial Contraction | 3 | 2020 | 343 | 0.220 |
Why?
| | Marketing | 1 | 2024 | 32 | 0.220 |
Why?
| | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2024 | 5 | 0.220 |
Why?
| | Exome | 1 | 2025 | 231 | 0.220 |
Why?
| | Echocardiography | 6 | 2022 | 659 | 0.220 |
Why?
| | Microvessels | 1 | 2025 | 86 | 0.220 |
Why?
| | Rheology | 2 | 2017 | 91 | 0.220 |
Why?
| | Ultrasonography | 3 | 2017 | 750 | 0.220 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2015 | 142 | 0.210 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2025 | 153 | 0.210 |
Why?
| | Arteries | 2 | 2018 | 269 | 0.210 |
Why?
| | Elementary Particle Interactions | 2 | 2013 | 4 | 0.210 |
Why?
| | Insulin | 2 | 2013 | 2398 | 0.200 |
Why?
| | Protein Corona | 1 | 2022 | 6 | 0.200 |
Why?
| | Carotid Arteries | 2 | 2017 | 206 | 0.200 |
Why?
| | Peroneal Neuropathies | 1 | 2022 | 2 | 0.200 |
Why?
| | Infant | 10 | 2024 | 9467 | 0.200 |
Why?
| | Tomography, X-Ray Computed | 3 | 2023 | 2681 | 0.190 |
Why?
| | Motor Neuron Disease | 1 | 2022 | 20 | 0.190 |
Why?
| | Radiculopathy | 1 | 2022 | 35 | 0.190 |
Why?
| | Pregnancy | 6 | 2025 | 6745 | 0.190 |
Why?
| | Mitral Valve Insufficiency | 1 | 2022 | 69 | 0.190 |
Why?
| | Respiratory-Gated Imaging Techniques | 3 | 2018 | 10 | 0.190 |
Why?
| | Osseointegration | 1 | 2022 | 71 | 0.190 |
Why?
| | Biomedical Engineering | 1 | 2021 | 27 | 0.190 |
Why?
| | Coronary Vessels | 2 | 2021 | 245 | 0.190 |
Why?
| | Artificial Intelligence | 1 | 2025 | 275 | 0.190 |
Why?
| | Anesthesia, General | 1 | 2022 | 73 | 0.180 |
Why?
| | Nanostructures | 1 | 2022 | 108 | 0.180 |
Why?
| | Healthy Volunteers | 3 | 2017 | 204 | 0.180 |
Why?
| | Body Fluids | 1 | 2021 | 66 | 0.180 |
Why?
| | Prenatal Care | 1 | 2024 | 288 | 0.180 |
Why?
| | Medicago truncatula | 1 | 2021 | 2 | 0.180 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 1042 | 0.180 |
Why?
| | Respiration | 1 | 2022 | 198 | 0.180 |
Why?
| | Glomerular Filtration Rate | 2 | 2022 | 746 | 0.180 |
Why?
| | Bioprosthesis | 3 | 2015 | 41 | 0.170 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2021 | 41 | 0.170 |
Why?
| | Glycopeptides | 1 | 2021 | 43 | 0.170 |
Why?
| | Creatinine | 1 | 2022 | 501 | 0.170 |
Why?
| | Early Detection of Cancer | 1 | 2025 | 420 | 0.170 |
Why?
| | Heme | 1 | 2021 | 79 | 0.170 |
Why?
| | Body Surface Area | 1 | 2020 | 34 | 0.170 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2021 | 101 | 0.170 |
Why?
| | Cardiac Catheterization | 6 | 2023 | 528 | 0.170 |
Why?
| | Plant Proteins | 1 | 2021 | 114 | 0.170 |
Why?
| | Consensus | 5 | 2021 | 685 | 0.170 |
Why?
| | Aortic Valve Insufficiency | 2 | 2018 | 47 | 0.170 |
Why?
| | Diagnostic Imaging | 2 | 2020 | 339 | 0.170 |
Why?
| | Sinus of Valsalva | 1 | 2019 | 10 | 0.170 |
Why?
| | Students, Pharmacy | 1 | 2021 | 97 | 0.160 |
Why?
| | Faculty | 1 | 2021 | 143 | 0.160 |
Why?
| | Intracranial Aneurysm | 1 | 2021 | 97 | 0.160 |
Why?
| | Mechanotransduction, Cellular | 1 | 2021 | 112 | 0.160 |
Why?
| | Radiography | 3 | 2024 | 834 | 0.160 |
Why?
| | Anti-Infective Agents | 1 | 2022 | 256 | 0.160 |
Why?
| | United Kingdom | 1 | 2020 | 324 | 0.160 |
Why?
| | Education, Pharmacy | 1 | 2021 | 120 | 0.160 |
Why?
| | Blood Volume | 2 | 2016 | 61 | 0.160 |
Why?
| | Echocardiography, Doppler, Color | 2 | 2022 | 40 | 0.150 |
Why?
| | Fetal Growth Retardation | 1 | 2025 | 565 | 0.150 |
Why?
| | Cigarette Smoking | 1 | 2020 | 102 | 0.150 |
Why?
| | Transcriptome | 1 | 2025 | 974 | 0.150 |
Why?
| | Aorta, Abdominal | 2 | 2015 | 46 | 0.150 |
Why?
| | Hemoglobins | 1 | 2021 | 356 | 0.150 |
Why?
| | Elastic Tissue | 1 | 2018 | 9 | 0.150 |
Why?
| | Endothelium, Vascular | 2 | 2016 | 923 | 0.150 |
Why?
| | Tricuspid Valve | 2 | 2015 | 30 | 0.150 |
Why?
| | Pharmacists | 1 | 2021 | 260 | 0.150 |
Why?
| | Neurobehavioral Manifestations | 1 | 1998 | 1 | 0.150 |
Why?
| | Muscarinic Antagonists | 1 | 1998 | 28 | 0.140 |
Why?
| | Turner Syndrome | 1 | 2018 | 53 | 0.140 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2024 | 614 | 0.140 |
Why?
| | Placenta | 1 | 2025 | 754 | 0.140 |
Why?
| | Anxiety Disorders | 1 | 2021 | 376 | 0.140 |
Why?
| | Prognosis | 7 | 2021 | 4031 | 0.140 |
Why?
| | Sleep | 1 | 2024 | 754 | 0.140 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 69 | 0.140 |
Why?
| | Alcoholism | 1 | 2024 | 805 | 0.140 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 93 | 0.130 |
Why?
| | Alcohol Drinking | 1 | 2024 | 824 | 0.130 |
Why?
| | Heart Transplantation | 1 | 2023 | 749 | 0.130 |
Why?
| | Peptide Fragments | 1 | 2021 | 708 | 0.130 |
Why?
| | Mesons | 2 | 2014 | 9 | 0.130 |
Why?
| | Blood Vessel Prosthesis | 1 | 2017 | 127 | 0.130 |
Why?
| | Motion | 3 | 2025 | 101 | 0.130 |
Why?
| | Chorionic Gonadotropin, beta Subunit, Human | 1 | 2016 | 16 | 0.130 |
Why?
| | Cryptorchidism | 1 | 2016 | 15 | 0.130 |
Why?
| | Mitral Valve | 1 | 2017 | 89 | 0.130 |
Why?
| | Thoracic Surgery | 1 | 2018 | 133 | 0.130 |
Why?
| | Blood Pressure | 3 | 2019 | 1776 | 0.130 |
Why?
| | Endocardium | 1 | 2016 | 34 | 0.130 |
Why?
| | Heart Rate | 1 | 2020 | 831 | 0.130 |
Why?
| | Hypospadias | 1 | 2016 | 29 | 0.120 |
Why?
| | Statistics, Nonparametric | 2 | 2012 | 434 | 0.120 |
Why?
| | Disease Progression | 6 | 2019 | 2755 | 0.120 |
Why?
| | Nitric Oxide | 1 | 2021 | 914 | 0.120 |
Why?
| | Analysis of Variance | 3 | 2014 | 1324 | 0.120 |
Why?
| | Pregnancy Trimester, First | 1 | 2016 | 142 | 0.120 |
Why?
| | Mitral Valve Annuloplasty | 1 | 2015 | 4 | 0.120 |
Why?
| | Splanchnic Circulation | 1 | 2015 | 10 | 0.120 |
Why?
| | Preoperative Care | 1 | 2017 | 356 | 0.120 |
Why?
| | Femoral Artery | 2 | 2013 | 178 | 0.120 |
Why?
| | Cerebrovascular Disorders | 1 | 2016 | 96 | 0.120 |
Why?
| | Computed Tomography Angiography | 1 | 2016 | 124 | 0.120 |
Why?
| | Angiography | 1 | 2015 | 209 | 0.110 |
Why?
| | Cohort Studies | 5 | 2021 | 5730 | 0.110 |
Why?
| | Biomedical Research | 1 | 2021 | 689 | 0.110 |
Why?
| | Treatment Outcome | 8 | 2024 | 10821 | 0.110 |
Why?
| | Portal Vein | 2 | 2015 | 120 | 0.110 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2015 | 44 | 0.110 |
Why?
| | Databases, Factual | 2 | 2017 | 1351 | 0.110 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 533 | 0.110 |
Why?
| | Neutrons | 1 | 2014 | 10 | 0.110 |
Why?
| | Coronary Artery Disease | 1 | 2021 | 703 | 0.110 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2014 | 43 | 0.110 |
Why?
| | Atherosclerosis | 2 | 2021 | 415 | 0.110 |
Why?
| | Subtraction Technique | 1 | 2013 | 23 | 0.110 |
Why?
| | Heart | 3 | 2023 | 660 | 0.110 |
Why?
| | Brain Mapping | 1 | 2017 | 610 | 0.110 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 324 | 0.110 |
Why?
| | Cerebrovascular Circulation | 1 | 2015 | 242 | 0.100 |
Why?
| | Scleroderma, Systemic | 1 | 2014 | 122 | 0.100 |
Why?
| | Carotid Artery, Internal | 1 | 2013 | 42 | 0.100 |
Why?
| | Endarterectomy, Carotid | 1 | 2013 | 49 | 0.100 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 198 | 0.100 |
Why?
| | Multimodal Imaging | 1 | 2013 | 116 | 0.100 |
Why?
| | Epilepsy, Partial, Motor | 1 | 2012 | 2 | 0.100 |
Why?
| | Europe | 1 | 2013 | 414 | 0.100 |
Why?
| | Epilepsy, Absence | 1 | 2012 | 9 | 0.100 |
Why?
| | Smoking | 1 | 2020 | 1639 | 0.100 |
Why?
| | Plaque, Atherosclerotic | 1 | 2013 | 57 | 0.100 |
Why?
| | Protons | 1 | 2013 | 91 | 0.100 |
Why?
| | Carotid Stenosis | 1 | 2013 | 91 | 0.100 |
Why?
| | Vascular Capacitance | 1 | 2012 | 4 | 0.100 |
Why?
| | Alzheimer Disease | 1 | 1998 | 559 | 0.090 |
Why?
| | Fasting | 1 | 2013 | 275 | 0.090 |
Why?
| | Age of Onset | 1 | 2013 | 522 | 0.090 |
Why?
| | Pulmonary Embolism | 1 | 2014 | 222 | 0.090 |
Why?
| | Signal-To-Noise Ratio | 2 | 2025 | 71 | 0.090 |
Why?
| | Systematized Nomenclature of Medicine | 2 | 2021 | 13 | 0.090 |
Why?
| | Surface Properties | 2 | 2022 | 414 | 0.090 |
Why?
| | Endothelial Cells | 1 | 2016 | 780 | 0.090 |
Why?
| | Aged, 80 and over | 4 | 2015 | 7593 | 0.080 |
Why?
| | Neoplasms | 1 | 2025 | 2666 | 0.080 |
Why?
| | Dilatation | 2 | 2021 | 65 | 0.080 |
Why?
| | Vasodilation | 1 | 2013 | 494 | 0.080 |
Why?
| | Diastole | 2 | 2020 | 150 | 0.080 |
Why?
| | Longitudinal Studies | 2 | 2014 | 2857 | 0.080 |
Why?
| | RNA | 1 | 2016 | 924 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2066 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2521 | 0.080 |
Why?
| | Patient-Specific Modeling | 2 | 2020 | 41 | 0.080 |
Why?
| | Swine | 3 | 2016 | 775 | 0.080 |
Why?
| | Seizures | 1 | 2012 | 431 | 0.070 |
Why?
| | Risk Factors | 6 | 2020 | 10356 | 0.070 |
Why?
| | Linear Models | 3 | 2017 | 851 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2016 | 2420 | 0.070 |
Why?
| | Heart-Assist Devices | 1 | 2013 | 550 | 0.070 |
Why?
| | Calibration | 2 | 2017 | 146 | 0.070 |
Why?
| | Peripheral Arterial Disease | 1 | 2013 | 474 | 0.070 |
Why?
| | Prostheses and Implants | 2 | 2022 | 141 | 0.070 |
Why?
| | Sheep | 2 | 2022 | 855 | 0.060 |
Why?
| | Blood Volume Determination | 2 | 2016 | 5 | 0.060 |
Why?
| | Body Mass Index | 1 | 2014 | 2369 | 0.060 |
Why?
| | Myocardial Infarction | 1 | 2013 | 1045 | 0.060 |
Why?
| | Liquid Biopsy | 1 | 2025 | 14 | 0.060 |
Why?
| | Vena Cava, Inferior | 2 | 2016 | 71 | 0.060 |
Why?
| | Elasticity | 2 | 2017 | 195 | 0.060 |
Why?
| | Stroke | 1 | 2013 | 1129 | 0.060 |
Why?
| | Organometallic Compounds | 2 | 2018 | 111 | 0.060 |
Why?
| | Patient Positioning | 1 | 2025 | 68 | 0.060 |
Why?
| | Gene Expression Profiling | 2 | 2025 | 1770 | 0.050 |
Why?
| | Alcoholic Beverages | 1 | 2024 | 30 | 0.050 |
Why?
| | Neural Conduction | 1 | 2024 | 86 | 0.050 |
Why?
| | Actigraphy | 1 | 2024 | 108 | 0.050 |
Why?
| | Pulsatile Flow | 2 | 2015 | 60 | 0.050 |
Why?
| | Technology | 1 | 2024 | 95 | 0.050 |
Why?
| | Animals | 8 | 2022 | 37011 | 0.050 |
Why?
| | Risk Assessment | 3 | 2018 | 3439 | 0.050 |
Why?
| | Bromocriptine | 1 | 2022 | 29 | 0.050 |
Why?
| | Fasciculation | 1 | 2022 | 2 | 0.050 |
Why?
| | Durapatite | 1 | 2022 | 37 | 0.050 |
Why?
| | Adsorption | 1 | 2022 | 147 | 0.050 |
Why?
| | Prevalence | 2 | 2023 | 2719 | 0.050 |
Why?
| | Titanium | 1 | 2022 | 82 | 0.050 |
Why?
| | Blood Pressure Determination | 2 | 2013 | 156 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 16 | 0.050 |
Why?
| | Cell Adhesion | 1 | 2022 | 467 | 0.040 |
Why?
| | Histidine | 1 | 2021 | 65 | 0.040 |
Why?
| | Blood Proteins | 1 | 2022 | 250 | 0.040 |
Why?
| | Collagen | 1 | 2023 | 447 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 619 | 0.040 |
Why?
| | Stents | 2 | 2015 | 528 | 0.040 |
Why?
| | Longevity | 1 | 2022 | 165 | 0.040 |
Why?
| | Sex Factors | 2 | 2017 | 2074 | 0.040 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2020 | 36 | 0.040 |
Why?
| | Printing, Three-Dimensional | 1 | 2021 | 94 | 0.040 |
Why?
| | Electromyography | 1 | 2022 | 400 | 0.040 |
Why?
| | Machine Learning | 1 | 2025 | 496 | 0.040 |
Why?
| | Biological Transport | 1 | 2021 | 416 | 0.040 |
Why?
| | Heart Failure | 1 | 2013 | 2222 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 59 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 683 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 145 | 0.040 |
Why?
| | Self Concept | 1 | 2021 | 260 | 0.040 |
Why?
| | Obesity | 2 | 2023 | 2974 | 0.040 |
Why?
| | Perfusion | 2 | 2017 | 212 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 1987 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 84 | 0.040 |
Why?
| | Overweight | 1 | 2023 | 554 | 0.040 |
Why?
| | User-Computer Interface | 1 | 2019 | 159 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1775 | 0.040 |
Why?
| | Gadolinium | 1 | 2018 | 82 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 154 | 0.040 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2017 | 18 | 0.040 |
Why?
| | Myocardium | 1 | 2023 | 1004 | 0.040 |
Why?
| | Vascular Resistance | 1 | 2019 | 372 | 0.030 |
Why?
| | Preoperative Period | 1 | 2017 | 131 | 0.030 |
Why?
| | Vena Cava, Superior | 1 | 2016 | 23 | 0.030 |
Why?
| | Genomic Library | 1 | 2016 | 17 | 0.030 |
Why?
| | Reaction Time | 1 | 1998 | 432 | 0.030 |
Why?
| | Liver Transplantation | 2 | 1994 | 872 | 0.030 |
Why?
| | Memory | 1 | 1998 | 257 | 0.030 |
Why?
| | DNA Methylation | 1 | 2021 | 644 | 0.030 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2015 | 18 | 0.030 |
Why?
| | Extracellular Fluid | 1 | 2015 | 30 | 0.030 |
Why?
| | Elastin | 1 | 2015 | 78 | 0.030 |
Why?
| | Risk | 1 | 2018 | 905 | 0.030 |
Why?
| | Splenic Artery | 1 | 2015 | 14 | 0.030 |
Why?
| | Liver Circulation | 1 | 2015 | 20 | 0.030 |
Why?
| | Mesenteric Artery, Superior | 1 | 2015 | 15 | 0.030 |
Why?
| | Australia | 1 | 2016 | 314 | 0.030 |
Why?
| | Pedigree | 1 | 2016 | 514 | 0.030 |
Why?
| | Hepatic Artery | 1 | 2015 | 61 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2021 | 895 | 0.030 |
Why?
| | Heart Atria | 1 | 2016 | 136 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2015 | 94 | 0.030 |
Why?
| | Protein Binding | 1 | 2021 | 2229 | 0.030 |
Why?
| | Cytokines | 1 | 2022 | 2095 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 547 | 0.030 |
Why?
| | Postoperative Period | 1 | 2015 | 344 | 0.030 |
Why?
| | Organ Preservation Solutions | 1 | 1994 | 46 | 0.030 |
Why?
| | Cell Count | 1 | 2014 | 321 | 0.030 |
Why?
| | Electrons | 1 | 2014 | 86 | 0.030 |
Why?
| | Organ Sparing Treatments | 1 | 2013 | 34 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2015 | 309 | 0.030 |
Why?
| | Oxygen | 1 | 2018 | 943 | 0.030 |
Why?
| | Organ Preservation | 1 | 1994 | 102 | 0.030 |
Why?
| | Observational Studies as Topic | 1 | 2013 | 116 | 0.030 |
Why?
| | Pericardium | 1 | 2013 | 56 | 0.030 |
Why?
| | Quality Control | 1 | 2013 | 171 | 0.030 |
Why?
| | Cyclosporine | 1 | 1994 | 268 | 0.020 |
Why?
| | Tacrolimus | 1 | 1994 | 199 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1800 | 0.020 |
Why?
| | Survival Rate | 1 | 2017 | 1980 | 0.020 |
Why?
| | Silicones | 1 | 2012 | 25 | 0.020 |
Why?
| | Sus scrofa | 1 | 2012 | 52 | 0.020 |
Why?
| | Compliance | 1 | 2012 | 47 | 0.020 |
Why?
| | Thermodynamics | 1 | 2014 | 421 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1524 | 0.020 |
Why?
| | Recurrence | 1 | 2015 | 1060 | 0.020 |
Why?
| | Forecasting | 1 | 2013 | 386 | 0.020 |
Why?
| | Meglumine | 1 | 2011 | 18 | 0.020 |
Why?
| | United States | 2 | 2018 | 14696 | 0.020 |
Why?
| | Abnormalities, Multiple | 1 | 2012 | 189 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 526 | 0.020 |
Why?
| | Cognition | 1 | 1998 | 1192 | 0.020 |
Why?
| | Heart Diseases | 1 | 2013 | 359 | 0.020 |
Why?
| | Pyocyanine | 1 | 1989 | 2 | 0.020 |
Why?
| | Phenazines | 1 | 1989 | 11 | 0.020 |
Why?
| | Mucociliary Clearance | 1 | 1989 | 46 | 0.020 |
Why?
| | Trachea | 1 | 1989 | 236 | 0.020 |
Why?
| | Scattering, Radiation | 1 | 2006 | 101 | 0.020 |
Why?
| | Microbubbles | 1 | 2006 | 49 | 0.020 |
Why?
| | Nanotubes | 1 | 2006 | 47 | 0.020 |
Why?
| | Liver | 1 | 1994 | 1940 | 0.010 |
Why?
| | Mice | 1 | 2022 | 17843 | 0.010 |
Why?
| | Particle Size | 1 | 2006 | 394 | 0.010 |
Why?
| | Cardioplegic Solutions | 1 | 1994 | 7 | 0.010 |
Why?
| | Raffinose | 1 | 1994 | 24 | 0.010 |
Why?
| | Allopurinol | 1 | 1994 | 64 | 0.010 |
Why?
| | Adenosine | 1 | 1994 | 227 | 0.010 |
Why?
| | Glutathione | 1 | 1994 | 358 | 0.010 |
Why?
| | Graft Survival | 1 | 1994 | 540 | 0.010 |
Why?
| | Tissue and Organ Procurement | 1 | 1994 | 314 | 0.010 |
Why?
| | Guinea Pigs | 1 | 1989 | 162 | 0.000 |
Why?
|
|
Barker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|